Nozomu Koyanagi
Nozomu Koyanagi publishes mostly in Molecular Biology, Organic Chemistry and Hepatology, on topics such as Enzyme function and inhibition, Cancer therapeutics and mechanisms and Synthesis and biological activity.
- World rank
- #2,338,794 of 7,710,434 ranked researchers
- Rank in Japan
- #45,848 of 383,136
- Works
- 24
- Citations
- 1.3k
- Citations per work
- 56.1
What does Nozomu Koyanagi research?
Nozomu Koyanagi's work is mostly in Biochemistry, Genetics and Molecular Biology (35%), Chemistry (26%), Medicine (11%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences939.0%
- Physical Sciences626.4%
- Chemistry626.4%
- Everything else623.4%
- Health Sciences311.2%
- Medicine311.2%
- 1Molecular Biology29% of their works
- 2Organic Chemistry26% of their works
- 3Hepatology6% of their works
- 4Biotechnology6% of their works
- 5Oncology6% of their works
- 6Toxicology4% of their works
Research topics
- Enzyme function and inhibition
- Cancer therapeutics and mechanisms
- Synthesis and biological activity
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research and Treatments
- Bioactive Compounds and Antitumor Agents
- Synthesis and Catalytic Reactions
- Synthesis and Characterization of Heterocyclic Compounds
Which keywords describe Nozomu Koyanagi's research?
The keywords of their largest research topics: Anticancer Agents, Inhibitors, Drug Discovery, Activators, Carbonic Anhydrases, Medicinal Chemistry, DNA and Synthesis.
- Antimicrobial
- Toxicology
- Catalytic
- Amination
- Liver Cancer
- Hepatocellular Carcinoma
- Synthesis
- Medicinal Chemistry
- Activators
- Inhibitors
- Anticancer Agents
- Drug Discovery
- Carbonic Anhydrases
- DNA
- Topoisomerases
- Heterocyclic Compounds
- Tubulin Inhibitors
- Bacterial Therapy
- Quinones
- Tumor Targeting
- Triazines
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Anticancer Agents153 topics
- Inhibitors132 topics
- Drug Discovery102 topics
- Activators81 topic
- Carbonic Anhydrases81 topic
- Medicinal Chemistry72 topics
- DNA51 topic
- Synthesis52 topics
- Topoisomerases51 topic
- Hepatocellular Carcinoma41 topic
- Heterocyclic Compounds41 topic
- Liver Cancer41 topic
- Tubulin Inhibitors41 topic
- Amination31 topic
- Bacterial Therapy31 topic
- Catalytic31 topic
- Quinones31 topic
- Toxicology31 topic
- Tumor Targeting31 topic
- Antimicrobial21 topic
- Triazines21 topic
Where does Nozomu Koyanagi work?
Nozomu Koyanagi's main affiliation in the publication record is Eisai (Japan), Japan.
How many publications and citations does Nozomu Koyanagi have?
OpenAlex counts 24 works and 1,346 citations for Nozomu Koyanagi, an h-index of 13, ranking #2,338,794 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Nozomu Koyanagi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.